Br J Ophthalmol 88:843-844 doi:10.1136/bjo.2003.033589
  • Letter

Pseudohypopyon after intravitreal triamcinolone injection for the treatment of pseudophakic cystoid macular oedema

  1. S D M Chen,
  2. J Lochhead,
  3. B McDonald,
  4. C K Patel
  1. Oxford Eye Hospital, Oxford, UK
  1. Correspondence to: S Chen Oxford Eye Hospital, Woodstock rd, Oxford OX2 6HE, UK;
  • Accepted 4 November 2003

Intravitreal triamcinolone injection is a safe and effective treatment for cystoid macular oedema (CMO) caused by uveitis,1 diabetic maculopathy,2 central retinal vein occlusion,3 and pseudophakic CMO.4 Potential risks include glaucoma, cataract, retinal detachment, and endophthalmitis.

We present a case of pseudohypopyon and sterile endophthalmitis following intravitreal triamcinolone injection for the treatment of pseudophakic CMO.

Case report

An 88 year old woman underwent phacoemulsification surgery which was complicated by posterior capsule rupture. Anterior vitrectomy with implantation of a silicone intraocular lens into the sulcus was performed. Postoperatively, CMO developed. This failed to respond to treatment with topical dexamethasone, topical ketorolac, and posterior sub-Tenon triamcinolone injection, limiting visual acuity to 6/24 at 7 months following the cataract surgery.

An intravitreal injection of triamcinolone acetonide (4 …